Comparable increase of B-type natriuretic peptide and amino-terminal pro-B-type natriuretic peptide levels in patients with severe sepsis, septic shock, and acute heart failure

Critical Care Medicine

Volumn 34, Issue 8, 2006, Pages 2140-2144

  Rudiger, Alain ^a   Gasser, Stefan ^b   Fischler, Manuel ^c   Hornemann, Thorsten ^d   Von Eckardstein, Arnold ^d   Maggiorini, Marco ^c  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b Internal Medicine   (Switzerland)

^c UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^d UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Amino terminal pro B type natriuretic peptide; B type natriuretic peptide; Heart failure; Inflammation; Myocardial dysfunction; Natriuretic peptide; Sepsis; Shock

Indexed keywords

AMINO TERMINAL TELOPEPTIDE; BRAIN NATRIURETIC PEPTIDE; PEPTIDE FRAGMENT; PRO BRAIN NATRIURETIC PEPTIDE (1 76); PRO-BRAIN NATRIURETIC PEPTIDE (1-76);

ACUTE HEART FAILURE; ADULT; AGED; ARTERY CATHETER; ARTICLE; CONTROLLED STUDY; FEMALE; HEART OUTPUT; HEMODYNAMICS; HUMAN; INTENSIVE CARE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PULMONARY ARTERY; PULMONARY ARTERY OCCLUSION; SEPSIS; SEPTIC SHOCK; STATISTICAL ANALYSIS; ACUTE DISEASE; BLOOD; BLOOD PRESSURE; CONGESTIVE HEART FAILURE; INTENSIVE CARE UNIT; LENGTH OF STAY; MIDDLE AGED; MORTALITY; SEX DIFFERENCE;

ACUTE DISEASE; AGED; BLOOD PRESSURE; FEMALE; HEART FAILURE, CONGESTIVE; HOSPITAL MORTALITY; HUMANS; INTENSIVE CARE UNITS; LENGTH OF STAY; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PROSPECTIVE STUDIES; SEPSIS; SEX FACTORS; SHOCK, SEPTIC;

EID: 33748110804     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.CCM.0000229144.97624.90     Document Type: Article

References (33)

1. Mukoyama M, Nakao K, Hosoda K, et al: Brain natriuretic peptide as a novel cardiac hormone in humans. J Clin Invest 1991; 87:1402-1412
2. Nakagawa O, Ogawa Y, Itoh H, et al: Rapid transcriptional activation and early mRNA turnover of brain natriuretic peptide in cardiocyte hypertrophy. J Clin Invest 1995; 96:1280-1287
3. Vanderheyden M, Bartunek J, Goethals M: Brain and other natriuretic peptides: Molecular aspects. Eur J Heart Fail 2004; 6:261-268
4. Hall C: Essential biochemistry and physiology of (NT-pro)BNP. Eur J Heart Fail 2004; 6:257-260
5. Troughton RW, Frampton CM, Yandle TG, et al: Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations. Lancet 2000; 355:1126-1130
6. Pfister R, Scholz M, Wielckens K, et al: Use of N-terminal pro-BNP in routine testing and comparsion to BNP. Eur J Heart Fail 2004; 6:289-293
7. Davis M, Espiner E, Richards G, et al: Plasma brain natriuretic peptide in assessment of acute dyspnoea. Lancet 1994; 343:440-444
8. Maisel AS, Krishnaswamy P, Nowak RM, et al: Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 2002; 347:161-167
9. Mueller C, Scholer A, Laule-Kilian K, et al: Use of B-type natriuretic peptide in the evaluation and management of acute dyspnea. N Engl J Med 2004; 350:647-654
10. Januzzi JL, Camargo CA, Anwaruddin S, et al: The N-terminal pro-BNP investigation of dyspnea in the emergency department (PRIDE) study. Am J Cardiol 2005; 95:948-954
11. Tsutamoto T, Wada A, Maeda K, et al: Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure: Prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction. Circulation 1997; 96:509-516
12. De Lemøs JA, Morrow DA, Bentley JH, et al: The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes. N Engl J Med 2001; 345:1014-1021
13. Omland T, Persson A, Ng L, et al: N-terminal pro-B-type natriuretic peptide and long-term mortality in acute coronary syndromes. Circulation 2002; 106:2913-2918
14. Kragelund C, Grønning B, Køber L, et al: N-terminal pro-B-type natriuretic peptide and long-term mortality in stable coronary heart disease. N Engl J Med 2005; 352:666-675
15. Witthaut R, Busch C, Fraunberger P, et al: Plasma atrial natriuretic peptide and brain natriuretic peptide are increased in septic shock: Impact of interleukin-6 and sepsis-associated left ventricular dysfunction. Intensive Care Med 2003; 29:1696-1702
16. McLean AS, Tang B, Nalos M, et al: Increased B-type natriuretic peptide (BNP) level is a strong predictor for cardiac dysfunction in intensive care unit patients. Anaesth Intensive Care 2003; 31:21-27
17. Jones AE, Kline JA: Elevated brain natriuretic peptide in septic patients without heart failure. Ann Emerg Med 2003; 42:714-715
18. Charpentier J, Luyt C-E, Fulla Y, et al: Brain natriuretic peptide: A marker of myocardial dysfunction and prognosis during severe sepsis. Crit Care Med 2004; 32:660-665
19. Tomaru K-i, Arai M, Yokoyama T, et al: Transcriptional activation of the BNP gene by lipopolysaccharide is mediated through GATA elements in neonatal rat cardiac myocytes. J Mol Cell Cardiol 2002; 34:649-659
20. Tanaka T, Kanda T, Takahashi T, et al: Interleukin-6 induced reciprocal expression of SERCA and natriuretic peptides mRNA in cultured rat ventricular myocytes. J Int Med Res 2004; 32:57-61
21. Ma KK, Ogawa T, de Bold AJ: Selective up-regulation of cardiac brain natriuretic peptide at the transcriptional and translational levels by pro-inflammatory cytokines and by conditioned medium derived from mixed lymphocyte reactions via p38 MAP kinase. J Mol Cell Cardiol 2004; 36:505-513
22. Bone RC, Balk R, Cerra F, et al: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest 1992; 101:1644-1655
23. Levy MM, Fink MP, Marshall JC, et al: 2001 SCCM/ESICM/ACCP/ATS/SIS international sepsis definitions conference. Crit Care Med 2003; 31:1250-1256
24. Poelaert J, Declerck C, Vogelaers D, et al: Left ventricular systolic and diastolic function in septic shock. Intensive Care Med 1997; 23:553-560
25. Kumar A, Haery C, Parrillo JE: Myocardial dysfunction in septic shock. Crit Care Clin 2000; 16:251-287
26. Bailén MR: Reversible myocardial dysfunction in critically ill, noncardiac patients: A review. Crit Care Med 2002; 30:1280-1290
27. Court O, Kumar A, Parrillo JE, et al: Myocardial depression in sepsis and septic shock. Crit Care 2002; 6:500-507
28. Tung RH, Garcia C, Morss AM, et al: Utility of B-type natriuretic peptide for the evaluation of intensive care unit shock. Crit Care Med 2004; 32:1643-1647
29. Papp A, Uusaro A, Parviainen I, et al: Myocardial function and haemodynamics in extensive burn trauma: Evaluation by clinical signs, invasive monitoring, echocardiography and cytocine concentrations - A prospective clincal study. Acta Anaesthesiol Scand 2003; 47:1257-1263
30. Vollmar AM, Schulz R: Expression and differential regulation of natriuretic peptides in mouse macrophages. J Clin Invest 1995; 95:2442-2450
31. Redfield MM, Rodeheffer RJ, Jacobsen SJ, et al: Plasma brain natriuretic peptide concentration: Impact of age and gender. J Am Coll Cardiol 2002; 40:976-982
32. McCullough PA, Duc P, Omland T, et al: B-type natriuretic peptide and renal function in the diagnosis of heart failure: An analysis from the breathing not properly multinational study. Am J Kidney Dis 2003; 41:571-579
33. McLean AS, Huang SJ, Nalos M, et al: The confounding effects of age, gender, serum creatinine, and electrolyte concentrations on plasma B-type natriuretic peptide concentrations in critically ill patients. Crit Care Med 2003; 31:2611-2618